The product as it actually stands in every territory

Pharmaceutical Product is the record of the product itself, and it holds almost nothing of its own. Its status in each territory, the formula registered there, the registrations open, the variations planned, the identifiers that name it: each one is a reference to the domain that owns it. So the product view is what the operation currently says, not a report someone assembled last quarter.

Domain owner
Head of Regulatory Operations · Master Data · Product Lifecycle
What it gathers
Status per territory · Registered formula · Open registrations · Planned variations · Identifiers
Standards covered
GS1 · FDA Listing (SPL) · EU EVMPD / IDMP · ATC / WHO · country-specific

Capabilities

  • Status in every territory

    Where the product stands in each market: registered, under review, suspended, withdrawn, and since when. Read from the filings themselves rather than kept as a parallel list someone has to remember to update.

    • Status per territory
    • Registration state
  • The formula registered in each territory

    The composition actually approved in each market, held territory by territory rather than as one global formula with its divergences noted somewhere else. Where two territories differ, the difference is visible as data instead of as institutional memory.

    • Registered formula
    • Territory composition
  • Registration projects in flight

    The registrations open against the product, the stage each has reached and what it is waiting on, so the question of what is being registered where has an answer rather than an owner.

    • Open registrations
    • Project stage
  • Variations planned and submitted

    The variations against the product, planned or in flight, with the territories each one touches and the filings it implies: connected to the change that prompted them rather than tracked separately from it.

    • Planned variations
    • Territories touched
  • Identifiers and codification

    GTIN-14 codes, NDC, EU PCID and country identifiers, MAH records and authorization linkage, SPL submissions to FDA Listing, reimbursement and pricing codes: every identifier the product is known by, held against the product rather than in a spreadsheet maintained by hand.

    • GTIN-14 · NDC · EU PCID
    • SPL · MAH · Reimbursement

Touchpoints

Regulatory Affairs

Filings, registrations and variations

The product's status, its open registrations and its planned variations are the filings themselves, read from Regulatory Affairs rather than restated beside it.

Market Access

Reimbursement and payer identifiers

Reimbursement codes, payer IDs, and tender identifiers feed market access work directly not as a one-off lookup project per market.

Labeling

Territory labels and pack-level identifiers

The label approved in a territory and the identifiers printed on its artwork resolve against the same product record, so a pack change surfaces what it touches.

Organizations & Resources

Partner identifiers and establishment registration

Contract manufacturers and packagers carry their establishment identifiers as part of the partner record so SPL submissions and country registrations inherit the partner data structurally.

Outcomes

  • Identifier consistency across systems

    Every system that consumes a product identifier reads it from the same master record: drift is a structural impossibility, not a periodic reconciliation.

  • Reimbursement holds caused by identifier mismatches

    Identifier issues surface before submission rather than as a rejection from a payer.

  • Time spent on master data reconciliation

    Reconciliation is replaced by single-source projection. The work becomes maintaining the master, not mediating between copies.

  • Identifier updates propagated per cycle

    When an identifier changes, every downstream system sees the change as a property of the data not as a manual update task.

Figures marked indicative are directional benchmarks against comparable generics operations; per-customer numbers replace them in working sessions.

Want to talk?

Same foundation under every domain. A conversation usually clarifies where to start.